CardiologyPlus2026年特刊征稿|結(jié)構(gòu)性心臟病的經(jīng)導(dǎo)管治療：現(xiàn)在和未來(lái)

Call for Paper

Topic:Transcatheter Therapies for Structural Heart Disease: Present and Futures

Main Purpose

This Special Issue will explore the current landscape and emerging developments in transcatheter therapies for structural heart disease. We will highlight contemporary practice, technological evolution, and future directions across aortic, mitral, and tricuspid interventions, as well as breakthrough innovations shaping the next era of minimally invasive cardiology.

Outline of Pathways

1. Updates in Transcatheter Aortic Valve Replacement (TAVR): clinical evidence, expanding indications, and future perspectives.

2. Transcatheter Mitral Valve Therapies: edge-to-edge repair, replacement technologies, and patient selection.

3. Advances in Transcatheter Tricuspid Interventions: devices, trials, and real-world outcomes.

4. Innovation in Structural Heart Disease: imaging advances, robotics, remote interventions, and AI-assisted planning.

5. Original Research and Clinical Studies: contemporary challenges, unmet needs, and next-generation solutions.

Words Limit

For other article types, please refer to author’s instructions:

https://journals.lww.com/cardioplus/Pages/instructionsforauthors.aspx

We welcome submissions of basic research, clinical studies, reviews, and innovative original articles related to transcatheter structural heart interventions. Accepted papers will be published continuously in the Cardiology Plus (as soon as accepted) and will be listed together on the Special Issue website.

Cardiology Plus submission system:

https://www.editorialmanager.com/cardioplus/default1.aspx

Please indicate in the cover letter that your article is for “Transcatheter Therapies for Structural Heart Disease: Present and Futures”. The submission deadline isFebruary 28,2026. We are looking forward to your contribution!

歡迎掃碼獲取期刊更多信息